Alcobra Ltd. Ord (ADHD) 4.77 $ADHD Alcobra Anno
Post# of 273257
Posted On: 09/03/2016 9:16:31 PM
Alcobra Ltd. Ord (ADHD) 4.77 $ADHD
Alcobra Announces Second Quarter 2016 Financial Results and Provides Corporate Update
GlobeNewswire - Tue Aug 30, 6:00AM CDT
Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to treat patients with cognitive disorders, including Attention Deficit Hyperactivity Disorder (ADHD) and Fragile X Syndrome, today announced financial results for the three and six months ended June 30, 2016, and provided a corporate update.
ADHD: 4.77 (+0.03)
VeriFone Systems (PAY) Q3 Earnings: What Lies in Store?
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 9:49AM CDT
VeriFone Systems, Inc. (PAY) is set to report results for the third quarter of fiscal 2016 on Sep 1.
ADHD: 4.77 (+0.03), GOOGL: 796.87 (+5.47), PAY: 16.81 (-3.29), AAPL: 107.73 (+1.00)
Deere's (DE) Q3 Earnings: What's in Store for the Stock?
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 5:05PM CDT
Deere (DE) is slated to report third-quarter fiscal 2016 results on Aug 19.
ASND: 19.40 (-0.24), ADHD: 4.77 (+0.03), DE: 84.05 (+0.50), BBY: 38.75 (+0.21)
Alcobra Ltd. to Release Second Quarter Financial Results and Host Corporate Update Conference Call & Webcast on Tuesday, August 30
GlobeNewswire - Mon Aug 15, 7:00AM CDT
Alcobra Ltd. (NasdaqGM:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive disorders, including Attention Deficit Hyperactivity Disorder (ADHD) and Fragile X Syndrome, today announced that it will report its financial results for the second quarter ended June 30, 2016 before the market open, and will host a corporate update conference call and webcast on Tuesday, August 30, at 8:30 am Eastern Time.
ADHD: 4.77 (+0.03)
Is a Surprise Coming for Alcobra (ADHD) This Earnings Season?
Zacks Equity Research - Zacks Investment Research - Tue Aug 09, 7:36AM CDT
Alcobra has earnings coming up pretty soon and events are shaping up quite nicely for its report.
ADHD: 4.77 (+0.03)
What's in Store for Adverum (ADVM) this Earnings Season?
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 9:47AM CDT
Adverum Biotechnologies, Inc. (ADVM) is expected to report second-quarter 2016 results on Aug 11.
ADVM: 3.74 (+0.19), ADHD: 4.77 (+0.03), AVXS: 34.60 (+0.07), REGN: 388.64 (-4.76)
Perrigo (PRGO) Q2 Earnings: Stock Likely to Disappoint?
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 9:25AM CDT
Perrigo Company (PRGO) is set to report second-quarter 2016 results on Aug 10. It recorded a positive earnings surprise of 1.16% last quarter.
PRGO: 90.75 (-0.50), ADHD: 4.77 (+0.03), MCRB: 10.13 (-0.02), IONS: 29.46 (-0.58)
What's in Store for Yelp Inc. (YELP) this Earnings Season?
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 8:19AM CDT
Yelp Inc. (YELP) is set to report second-quarter 2016 results on Aug 9.
AMZN: 772.44 (+1.82), GRUB: 41.47 (+0.41), ADHD: 4.77 (+0.03), YELP: 38.78 (-0.11)
What's in Store for Intrexon (XON) This Earnings Season?
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 3:09AM CDT
Intrexon (XON), which is set to report second-quarter 2016 results on Aug 9, posted a negative surprise of 10.34% last quarter.
ADHD: 4.77 (+0.03), XON: 25.33 (+0.04), MCRB: 10.13 (-0.02), IONS: 29.46 (-0.58)
Will Q2 Earnings Hold a Surprise for Davita (DVA) Stock?
Zacks Equity Research - Zacks Investment Research - Fri Aug 05, 9:14AM CDT
DaVita HealthCare Partners Inc. (DVA) is set to report second-quarter 2016 results after the market closes on Aug 8.
DVA: 64.78 (+0.59), ADHD: 4.77 (+0.03), AST: 2.96 (+0.14), ALQA: 0.89 (+0.02)
Jazz (JAZZ) Q2 Earnings: Will the Stock Disappoint?
Arpita Dutt - Zacks Investment Research - Fri Aug 05, 6:45AM CDT
Our proven model does not conclusively show that Jazz (JAZZ) is likely to beat earnings estimates this quarter.
IPXL: 24.03 (+0.09), ADHD: 4.77 (+0.03), JAZZ: 120.84 (-2.47), INCY: 82.02 (+1.21)
Alcobra (ADHD) Looks Good: Stock Adds 14.4% in Session
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 7:25AM CDT
Alcobra Ltd. (ADHD) moved big last session, as its shares jumped over 14% on the day.
ADHD: 4.77 (+0.03)
Alcobra Ltd. to Participate in Upcoming Investment Conferences
GlobeNewswire - Wed Jun 01, 7:00AM CDT
Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to treat patients with cognitive disorders, including Attention Deficit Hyperactivity Disorder (ADHD) and Fragile X Syndrome (Fragile X), today announced corporate presentations at the upcoming Jefferies 2016 Healthcare Conference and the ROTH 3 Annual Healthcare Day.
ADHD: 4.77 (+0.03)
Alcobra (ADHD) Catches Eye: Stock Adds 6.3% in Session
Zacks Equity Research - Zacks Investment Research - Fri May 20, 7:30AM CDT
Alcobra Ltd (ADHD) was a big mover last session, as the company saw its shares rise over 6% on the day.
ADHD: 4.77 (+0.03), JNP: 5.56 (+0.05)
The Zacks Analyst Blog Highlights: Alcobra, Editas Medicine, Syndax Pharmaceuticals, Seres Therapeutics and Neos Therapeutics
Zacks Equity Research - Zacks Investment Research - Mon May 16, 8:30AM CDT
The Zacks Analyst Blog Highlights: Alcobra, Editas Medicine, Syndax Pharmaceuticals, Seres Therapeutics and Neos Therapeutics
SNDX: 14.01 (+0.07), EDIT: 16.11 (-0.63), ADHD: 4.77 (+0.03), MCRB: 10.13 (-0.02), NEOS: 7.00 (-0.10)
Alcobra reports 1Q loss
Automated Insights - Mon May 16, 7:15AM CDT
TEL AVIV, Israel (AP) _ Alcobra Ltd. (ADHD) on Monday reported a loss of $5.1 million in its first quarter.
ADHD: 4.77 (+0.03)
Alcobra Announces First Quarter 2016 Financial Results and Provides Corporate Update
GlobeNewswire - Mon May 16, 7:00AM CDT
-- Conference Call & Webcast May 16th at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time
ADHD: 4.77 (+0.03)
Drug Stocks' Earnings to Watch on May 16: ADHD, MCRB & More
Zacks Equity Research - Zacks Investment Research - Fri May 13, 8:26AM CDT
What's in store for drug stocks, Alcobra, Seres and others when they report their first-quarter results on May 16?
SNDX: 14.01 (+0.07), EDIT: 16.11 (-0.63), ADHD: 4.77 (+0.03), MCRB: 10.13 (-0.02), NEOS: 7.00 (-0.10)
Alcobra Ltd. to Release First Quarter Financial Results and Host Corporate Update Conference Call & Webcast on May 16
GlobeNewswire - Wed May 04, 7:00AM CDT
Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive disorders, including Attention Deficit Hyperactivity Disorder (ADHD) and Fragile X Syndrome, today announced that it will report its financial results for the first quarter ended March 31, 2016 before the market open, and will host a corporate update conference call and webcast on Monday, May 16, at 8:30 am Eastern Time.
ADHD: 4.77 (+0.03)
MEI Pharma (MEIP) in Focus: Stock Rises 7.9% in Session
Zacks Equity Research - Zacks Investment Research - Tue Apr 12, 7:35AM CDT
MEI Pharma, Inc. (MEIP) was a big mover last session, as the company saw its shares climb nearly 8% on the day.
ADHD: 4.77 (+0.03), MEIP: 1.76 (+0.02)
Alcobra Announces Second Quarter 2016 Financial Results and Provides Corporate Update
GlobeNewswire - Tue Aug 30, 6:00AM CDT
Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to treat patients with cognitive disorders, including Attention Deficit Hyperactivity Disorder (ADHD) and Fragile X Syndrome, today announced financial results for the three and six months ended June 30, 2016, and provided a corporate update.
ADHD: 4.77 (+0.03)
VeriFone Systems (PAY) Q3 Earnings: What Lies in Store?
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 9:49AM CDT
VeriFone Systems, Inc. (PAY) is set to report results for the third quarter of fiscal 2016 on Sep 1.
ADHD: 4.77 (+0.03), GOOGL: 796.87 (+5.47), PAY: 16.81 (-3.29), AAPL: 107.73 (+1.00)
Deere's (DE) Q3 Earnings: What's in Store for the Stock?
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 5:05PM CDT
Deere (DE) is slated to report third-quarter fiscal 2016 results on Aug 19.
ASND: 19.40 (-0.24), ADHD: 4.77 (+0.03), DE: 84.05 (+0.50), BBY: 38.75 (+0.21)
Alcobra Ltd. to Release Second Quarter Financial Results and Host Corporate Update Conference Call & Webcast on Tuesday, August 30
GlobeNewswire - Mon Aug 15, 7:00AM CDT
Alcobra Ltd. (NasdaqGM:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive disorders, including Attention Deficit Hyperactivity Disorder (ADHD) and Fragile X Syndrome, today announced that it will report its financial results for the second quarter ended June 30, 2016 before the market open, and will host a corporate update conference call and webcast on Tuesday, August 30, at 8:30 am Eastern Time.
ADHD: 4.77 (+0.03)
Is a Surprise Coming for Alcobra (ADHD) This Earnings Season?
Zacks Equity Research - Zacks Investment Research - Tue Aug 09, 7:36AM CDT
Alcobra has earnings coming up pretty soon and events are shaping up quite nicely for its report.
ADHD: 4.77 (+0.03)
What's in Store for Adverum (ADVM) this Earnings Season?
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 9:47AM CDT
Adverum Biotechnologies, Inc. (ADVM) is expected to report second-quarter 2016 results on Aug 11.
ADVM: 3.74 (+0.19), ADHD: 4.77 (+0.03), AVXS: 34.60 (+0.07), REGN: 388.64 (-4.76)
Perrigo (PRGO) Q2 Earnings: Stock Likely to Disappoint?
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 9:25AM CDT
Perrigo Company (PRGO) is set to report second-quarter 2016 results on Aug 10. It recorded a positive earnings surprise of 1.16% last quarter.
PRGO: 90.75 (-0.50), ADHD: 4.77 (+0.03), MCRB: 10.13 (-0.02), IONS: 29.46 (-0.58)
What's in Store for Yelp Inc. (YELP) this Earnings Season?
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 8:19AM CDT
Yelp Inc. (YELP) is set to report second-quarter 2016 results on Aug 9.
AMZN: 772.44 (+1.82), GRUB: 41.47 (+0.41), ADHD: 4.77 (+0.03), YELP: 38.78 (-0.11)
What's in Store for Intrexon (XON) This Earnings Season?
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 3:09AM CDT
Intrexon (XON), which is set to report second-quarter 2016 results on Aug 9, posted a negative surprise of 10.34% last quarter.
ADHD: 4.77 (+0.03), XON: 25.33 (+0.04), MCRB: 10.13 (-0.02), IONS: 29.46 (-0.58)
Will Q2 Earnings Hold a Surprise for Davita (DVA) Stock?
Zacks Equity Research - Zacks Investment Research - Fri Aug 05, 9:14AM CDT
DaVita HealthCare Partners Inc. (DVA) is set to report second-quarter 2016 results after the market closes on Aug 8.
DVA: 64.78 (+0.59), ADHD: 4.77 (+0.03), AST: 2.96 (+0.14), ALQA: 0.89 (+0.02)
Jazz (JAZZ) Q2 Earnings: Will the Stock Disappoint?
Arpita Dutt - Zacks Investment Research - Fri Aug 05, 6:45AM CDT
Our proven model does not conclusively show that Jazz (JAZZ) is likely to beat earnings estimates this quarter.
IPXL: 24.03 (+0.09), ADHD: 4.77 (+0.03), JAZZ: 120.84 (-2.47), INCY: 82.02 (+1.21)
Alcobra (ADHD) Looks Good: Stock Adds 14.4% in Session
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 7:25AM CDT
Alcobra Ltd. (ADHD) moved big last session, as its shares jumped over 14% on the day.
ADHD: 4.77 (+0.03)
Alcobra Ltd. to Participate in Upcoming Investment Conferences
GlobeNewswire - Wed Jun 01, 7:00AM CDT
Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to treat patients with cognitive disorders, including Attention Deficit Hyperactivity Disorder (ADHD) and Fragile X Syndrome (Fragile X), today announced corporate presentations at the upcoming Jefferies 2016 Healthcare Conference and the ROTH 3 Annual Healthcare Day.
ADHD: 4.77 (+0.03)
Alcobra (ADHD) Catches Eye: Stock Adds 6.3% in Session
Zacks Equity Research - Zacks Investment Research - Fri May 20, 7:30AM CDT
Alcobra Ltd (ADHD) was a big mover last session, as the company saw its shares rise over 6% on the day.
ADHD: 4.77 (+0.03), JNP: 5.56 (+0.05)
The Zacks Analyst Blog Highlights: Alcobra, Editas Medicine, Syndax Pharmaceuticals, Seres Therapeutics and Neos Therapeutics
Zacks Equity Research - Zacks Investment Research - Mon May 16, 8:30AM CDT
The Zacks Analyst Blog Highlights: Alcobra, Editas Medicine, Syndax Pharmaceuticals, Seres Therapeutics and Neos Therapeutics
SNDX: 14.01 (+0.07), EDIT: 16.11 (-0.63), ADHD: 4.77 (+0.03), MCRB: 10.13 (-0.02), NEOS: 7.00 (-0.10)
Alcobra reports 1Q loss
Automated Insights - Mon May 16, 7:15AM CDT
TEL AVIV, Israel (AP) _ Alcobra Ltd. (ADHD) on Monday reported a loss of $5.1 million in its first quarter.
ADHD: 4.77 (+0.03)
Alcobra Announces First Quarter 2016 Financial Results and Provides Corporate Update
GlobeNewswire - Mon May 16, 7:00AM CDT
-- Conference Call & Webcast May 16th at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time
ADHD: 4.77 (+0.03)
Drug Stocks' Earnings to Watch on May 16: ADHD, MCRB & More
Zacks Equity Research - Zacks Investment Research - Fri May 13, 8:26AM CDT
What's in store for drug stocks, Alcobra, Seres and others when they report their first-quarter results on May 16?
SNDX: 14.01 (+0.07), EDIT: 16.11 (-0.63), ADHD: 4.77 (+0.03), MCRB: 10.13 (-0.02), NEOS: 7.00 (-0.10)
Alcobra Ltd. to Release First Quarter Financial Results and Host Corporate Update Conference Call & Webcast on May 16
GlobeNewswire - Wed May 04, 7:00AM CDT
Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive disorders, including Attention Deficit Hyperactivity Disorder (ADHD) and Fragile X Syndrome, today announced that it will report its financial results for the first quarter ended March 31, 2016 before the market open, and will host a corporate update conference call and webcast on Monday, May 16, at 8:30 am Eastern Time.
ADHD: 4.77 (+0.03)
MEI Pharma (MEIP) in Focus: Stock Rises 7.9% in Session
Zacks Equity Research - Zacks Investment Research - Tue Apr 12, 7:35AM CDT
MEI Pharma, Inc. (MEIP) was a big mover last session, as the company saw its shares climb nearly 8% on the day.
ADHD: 4.77 (+0.03), MEIP: 1.76 (+0.02)
(0)
(0)Scroll down for more posts ▼